1887

Journal of General Virology header logo

Volume 73, Issue 8

Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein Free

Abstract

Local secretory immunity in the vagina may confer a degree of protection against heterosexual transmission of human immunodeficiency virus (HIV). Since the vagina has been shown to respond to local immunization, we have undertaken intravaginal immunization of rats with a 20-mer peptide (amino acid residues 102 to 121) of the HIV-1 envelope glycoprotein (gp120). The peptide was administered in combination with an ‘absorption enhancer’, lysophosphatidyl glycerol (LPG), which has previously been shown to promote the absorption of intravaginally administered peptides, while exerting only mild effects on epithelial membrane integrity. Intravaginal immunization with LPG and the peptide induced serum and vaginal wash IgA and IgG antibody responses which were enhanced in comparison to those after immunization with the peptide alone. Serum antibodies induced by both subcutaneous and intravaginal immunization were able to recognize recombinant HIV-1 gp120. However, the rat antiserum displayed no neutralizing activity against the virus. These results demonstrate that LPG is an effective immunological adjuvant for intravaginally administered peptide antigens. An alternative absorption enhancer, bestatin (BES), was not effective as an immunological adjuvant when administered intravaginally and blocked the adjuvant activity of LPG when BES and LPG were used in combination.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1992
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-8-2141
1992-08-01
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/8/JV0730082141.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-8-2141&mimeType=html&fmt=ahah

References

  1. Ahmar W. E., Poumbourios P., McPhee D. A., Kemp B. E. 1991; N-terminal residues 105-117 of HIV-1 gp120 are not involved in CD4 binding. AIDS Research and Human Retroviruses 7:855–858
     [Google Scholar]
  2. Belec L., Georges A. J., Steenman G., Martin P. M. V. 1989a; Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. Journal of Infectious Diseases 160:385–391
     [Google Scholar]
  3. Belec L., Peghini M., Georges A. J., Barabe P., Martin P. M. V. 1989b; Antibodies to HIV-2 in genital secretions. Research in Virology 140:15–21
     [Google Scholar]
  4. Berzofsky J. A. 1991; Development of artificial vaccines against HIV using defined epitopes. FASEB Journal 5:2412–2418
     [Google Scholar]
  5. Cease K. B., Margalit H., Cornette J. L., Putney S. D., Robey W. G., Ouyang C., Streicher H. Z., Fischinger P. J., Gallo R. C., DeLisi C., Berzofsky J. A. 1987; Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using 16-residue synthetic peptide. Proceedings of the National Academy of Sciences, U.S.A 84:4249–4253
     [Google Scholar]
  6. Clerici M., Lucey D. R., Zajac R. A., Boswell R. N., Gebel H. M., Takahashi H., Berzofsky J. A., Shearer G. M. 1991; Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. Journal of Immunology 146:2214–2219
     [Google Scholar]
  7. Davis D., Stephens D. M., Willers C., Lachmann P. J. 1990; Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1. Journal of General Virology 71:2889–2898
     [Google Scholar]
  8. Forrest B. D. 1991; Women, HIV, and mucosal immunity. Lancet 337:835–836
     [Google Scholar]
  9. McDermott M. R., Brais L. J., Evelegh M. J. 1990; Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. Journal of General Virology 71:1497–1504
     [Google Scholar]
  10. McKeating J. A., McKnight A., McIntosh K., Clapham P. R., Mulder C. A., Weiss R. A. 1989; Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. Journal of General Virology 70:3327–3333
     [Google Scholar]
  11. Merriman H., Woods S., Winter C., Fahnlander A., Corey C. 1984; Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus. Journal of Infectious Diseases 149:505–510
     [Google Scholar]
  12. Mestecky J., McGhee J. R. 1987; Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Advances in Immunology 40:153–245
     [Google Scholar]
  13. Miller C., Gardner M. B. 1991; AIDS and mucosal immunity: usefulness of the SIV macaque model of genital mucosal transmission. Journal of Acquired Immune Deficiency Syndromes 4:1169–1172
     [Google Scholar]
  14. Miller C. J., Alexander N. J., Sutjipto S., Lackner A. A., Gettie A., Hendrickx A. G., Lowenstine L. J., Jennings M., Marx P. A. 1989; Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. Journal of Virology 63:4277–4284
     [Google Scholar]
  15. Moore J. P., Wallace L. A., Follet E. A. C., McKeating J. A. 1989; An enzyme linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS 3:155–163
     [Google Scholar]
  16. Moore J. P., McKeating J. A., Jones I. M., Stephens P. E., Clements G., Thomson S., Weiss R. A. 1990; Characterisation of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and sCD4. AIDS 4:307–315
     [Google Scholar]
  17. Neurath A. R., Strick N., Lee E. S. Y. 1990; B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides. Journal of General Virology 71:85–95
     [Google Scholar]
  18. Ogra P. L., Ogra S. S. 1973; Local antibody response to polio vaccine in the human female genital tract. Journal of Immunology 110:1307–1311
     [Google Scholar]
  19. O‘Hagan D. T., Illum L. 1990; Absorption of peptides and proteins from the respiratory tract and the potential for the development of locally administered vaccines. CRC Critical Reviews in Therapeutic Drug Carrier Systems 7:35–97
     [Google Scholar]
  20. O’Hagan D. T., Rahman D., McGhee J. P., Jeffery H., Davies M. C., Williams P., Davis S. S., Challacombe S. J. 1991; Biodegradable microparticles as controlled release antigen delivery systems. Immunology 73:239–242
     [Google Scholar]
  21. O‘Reilly R. J., Lee L., Welch B. G. 1976; Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. Journal of Infectious Diseases 133:113–125
     [Google Scholar]
  22. Parr E. L., Parr M. B. 1990; Antigen recognition in the female reproductive tract. I. Uptake of intraluminal protein tracers in the mouse vagina. Journal of Reproductive Immunology 17:101–114
     [Google Scholar]
  23. Parr E. L., Parr M. B., Thaparr M. A. 1988; A comparison of specific antibody responses in mouse vaginal fluid after immunization by several routes. Journal of Reproductive Immunology 14:165–176
     [Google Scholar]
  24. Parr M. B., Parr E. L. 1985; Immunohistochemical localization of immunoglobulins A, G and M in the mouse female genital tract. Journal of Reproduction and Fertility 74:361–370
     [Google Scholar]
  25. Renegar K. B., Small P. A. Jr 1991; Passive transfer of local immunity to influenza virus infection by IgA antibody. Journal of Immunology 146:1972–1978
     [Google Scholar]
  26. Richardson J. L., Thomas N. W., Illum L. 1992; Vaginal absorption of insulin in the rat. Effect of penetration enhancers on peptide uptake and mucosal histology.. Pharmaceutical Research (in press)
    [Google Scholar]
  27. Robinson W. E., Montefiore D. C., Mitchell W. M. 1988; Antibody dependent enhancement of human immunodeficiency virus type 1 infection. Lancet i:790–794
     [Google Scholar]
  28. Shafferman A., Jahrling P. B., Benveniste R. E., Lewis M. G., Phipps T. J., Eden-McCutchan F., Sadoff J., Eddy G. A., Burke D. S. 1991; Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proceedings of the National Academy of Sciences, U.S.A. 88:7126–7130
     [Google Scholar]
  29. Sutjipto S., Pedersen N. C., Miller C. J., Gardner M. B., Hanson C. V., Gettie A., Jennings M., Higgins J., Marx P. A. 1990; Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. Journal of Virology 64:2290–2297
     [Google Scholar]
  30. Thaparr M. A., Parr E. L., Parr M. B. 1990; The effect of adjuvants on antibody titres in mouse vaginal fluid after intravaginal immunization. Journal of Reproductive Immunology 17:207–216
     [Google Scholar]
  31. Thaparr M. A., Parr E. L., Bozzola J. J., Parr M. B. 1991; Secretory immune response in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (iscom). Vaccine 9:129–133
     [Google Scholar]
  32. Umezawa H. 1984; Studies on low molecular weight immunomodi-fiers, bestatin etc. Discovery and actions.. Drugs in Experimental and Clinical Research 8–9:519–531
     [Google Scholar]
  33. Vahlne A., Horal P., Eriksson K., Jeansson S., Rymo L., Hedstrom K. G., Czerkinsky C., Holmgren J., Svenner-holm B. 1991; Immunizations of monkeys with synthetic peptides disclose conserved areas on gp 120 of human immunodeficiency virus type-1 associated with cross-neutralizing antibodies and T-cell recognition. Proceedings of the National Academy of Sciences, U.S.A 88:10744–10748
     [Google Scholar]
  34. Waldman R. H., Cruz J. M., Rowe D. S. 1972; Intravaginal immunization of humans with Candida albicans . Journal of Immunology 109:662–664
     [Google Scholar]
  35. Wolfsy C. B., Hauer L. B., Michaelis B. A., Cohen J. B., Padian N. S., Evans L. A., Levy J. A. 1986; Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet i527–529
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-8-2141
Loading
Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein
J. Gen. Virol. 73, 2141 (1992); https://doi.org/10.1099/0022-1317-73-8-2141
/content/journal/jgv/10.1099/0022-1317-73-8-2141
/content/journal/jgv/10.1099/0022-1317-73-8-2141
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error